Federated Hermes
CRDF icon

Federated Hermes’s Cardiff Oncology CRDF Stock Holding History

Federated Hermes’s Portfolio CRDF Stock Details CRDF Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$3.65K Buy
+2,253
New +$4.63K ﹤0.01% 1921
2022
Q3 		– Sell
-196
Closed -$1K – 2157
2022
Q2 		$1K Buy
196
+44
+29% +$74 ﹤0.01% 2033
2022
Q1 		$1K Buy
+152
New +$538 ﹤0.01% 2074

Other funds holding CRDF

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
LCM
Laurion Capital Management New York $2.29B AUM 75.73% 1-Year Est. Return
P
Pfizer New York $239M AUM 232.47% 1-Year Est. Return
ACA
Acorn Capital Advisors New York $352M AUM 299.18% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
William Blair & Company
William Blair & Company Chicago, Illinois $34.9B AUM 18.88% 1-Year Est. Return
FLPIM
F.L. Putnam Investment Management Lynnfield, Massachusetts $6.71B AUM 23.99% 1-Year Est. Return

Federated Hermes's CRDF Position: Q1 2026 in Review

Federated Hermes opened a new position in Cardiff Oncology (CRDF) in Q1 2026: 2,253 shares worth $3.65K. The stake represents ﹤0.01% of the portfolio and ranks #1921 among its holdings. This is a return to the name: Federated Hermes previously reported a position in CRDF as recently as Q2 2022.

Federated Hermes first reported a position in CRDF in Q1 2022 and has held it in 3 quarters since. 116 funds tracked by Wall St. Rank hold CRDF as of Q1 2026.

  • Federated Hermes held 2,253 shares of Cardiff Oncology worth $3.65K as of Q1 2026.
  • Cardiff Oncology was a new Federated Hermes position in Q1 2026.
  • Cardiff Oncology made up ﹤0.01% of Federated Hermes's portfolio in Q1 2026, its #1921 holding.
  • Federated Hermes first reported a position in Cardiff Oncology in Q1 2022 and has held it in 3 quarters since.
  • 116 funds tracked by Wall St. Rank held Cardiff Oncology as of Q1 2026.

Based on Federated Hermes's 13F filing for Q1 2026, filed 11 May 2026.